FIELD: medicine.
SUBSTANCE: invention relates to medicine. Described is a method for treating a patient with a degenerative bone condition. Said method comprises the formation of a void in a localized region of a degenerative bone and filling the void with bone regeneration material, which results in the formation of a new healthy natural bone material.
EFFECT: method is suitable for improving bone quality in a localized region of a degenerative bone, such as osteopenic or osteoporotic bone, by improving bone mineral density (BMD) up to achieving a substantially similar BMD of an average healthy person at the age of the BMD peak.
10 cl, 34 dwg, 9 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF TREATING DEGENERATIVE BONE CONDITIONS | 2011 |
|
RU2578032C2 |
METHOD FOR PREVENTION OF LONG TUBULAR BONES FRACTURES IN OSTEOPOROSIS | 2021 |
|
RU2757959C1 |
TREATMENT OF PATHOLOGICAL BONE CONDITIONS IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY | 2018 |
|
RU2795570C2 |
PTH-CONTAINING THERAPEUTIC/PROPHILACTIC ANTI-OSTEOPOROSIS AGENT, CHARACTERISED BY WEEKLY INTRODUCTION OF PTH IN STANDARD DOSE OF 100-200 UNITS | 2010 |
|
RU2564894C2 |
COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2565020C2 |
METHOD AND DEVICE FOR ESTIMATING MINERAL DENSITY OF A BONE | 2011 |
|
RU2598642C2 |
DRUG PREPARATION USED FOR CARTILAGE DISEASES | 2006 |
|
RU2454999C2 |
PROBIOTIC STRAINS FOR APPLICATION IN OSTEOPOROSIS TREATMENT OR PREVENTION | 2014 |
|
RU2636027C2 |
COMPLEMENTED MATRIXES FOR TREATING BONE FRACTURES | 2006 |
|
RU2422172C2 |
APPLICATION OF HESPERIDINE OR ONE OF ITS DERIVATIVES FOR MANUFACTURING MEDICINAL PREPARATION INDICATED FOR OSTEOGENESIS STIMULATION | 2003 |
|
RU2320346C2 |
Authors
Dates
2018-09-28—Published
2011-06-30—Filed